Hyperinsulinemia and insulin resistance frequently coexist and have been implicated in the pathogenesis of hypertension. This study aimed to identify the specific effect of hyperinsulinemia on blood pressure and nitric oxide (NO) release in fructose-induced hyperinsulinemic, insulin-resistant rats. Male Sprague-Dawley rats were fed either standard chow or a 60% fructose-enriched diet for 8 weeks before acute study. After basal period, somatostatin (1.3 g/kg/min) and a variable glucose infusion (to maintain euglycemia) were given intravenously to all groups of rats. In control rats (C) and fructose-fed rats (F) with insulin infusion, insulin (4 mU/kg/min) was given to create a similar hyperinsulinemic condition. In C and F without insulin infusion, a vehicle instead of insulin was infused to produce a hypoinsulinemic state. In C, somatostatin reduced plasma insulin level but did not alter mean arterial pressure (MAP) and heart rate. Insulin infusion significantly increased MAP and NOx (sum of nitrate and nitrite) levels after 90 min and thereafter the elevated MAP and NOx responses were sustained throughout the study. In the basal period, F exhibited significantly higher MAP and plasma insulin levels than C. The index of insulin sensitivity (M) was significantly lower in F than in C with insulin infusion. Somatostatin significantly reduced plasma insulin level but did not affect MAP and NOx level in F. The stimulatory effects of insulin on MAP and NO levels were significantly smaller in F than in C. In conclusion, acute insulin-induced pressor response and NO release were attenuated in rats with fructose-treated insulin resistance, suggesting that hyperinsulinemia-associated attenuation of NO production contributes, at least partly, to the development of fructose-induced hypertension in rats. H yperinsulinemia and insulin resistance were found to be common in essential hypertension, even without obesity, and are the foundation for the concept of the metabolic syndrome X.
H
yperinsulinemia and insulin resistance were found to be common in essential hypertension, even without obesity, and are the foundation for the concept of the metabolic syndrome X. 1, 2 In addition, hyperinsulinemia or insulin resistance have been postulated to contribute to the pathophysiology of cardiovascular diseases such as hypertension and atherosclerosis. 3, 4 Although insulin can acutely alter neural, [5] [6] [7] renal, 8 -10 and vascular functions and induce nitric oxide (NO) release 11 as well, the precise role of hyperinsulinemia and insulin resistance in causing long-term changes in cardiovascular function is still unclear. Much of our knowledge of the chronic cardiovascular actions of insulin is based on the extrapolations from acute studies or on the correlations and associations between insulin and various cardiovascular changes, rather than experimentally established, direct cause and effect relationships. Furthermore, it has also been difficult to differentiate and quantify the distinct effects of hyperinsulinemia and insulin resistance on the pathogenesis of cardiovascular diseases. This is because hyperinsulinemia and insulin resistance coexist and are often associated with other metabolic abnormalities that influence cardiovascular functions. [12] [13] [14] [15] Hyperinsulinemia/insulin resistance and hypertension have also been documented in the fructose-induced hypertensive rat model. 16, 17 Although the precise mechanism has not been clearly elucidated, it has been proposed that hypertension in fructose-fed rats is secondary to the development of insulin resistance/hyperinsulinemia. 18, 19 Thus, the fructose-induced hypertensive rat is an appropriate animal model for evaluating the contribution of changes in the states of hyperinsulinemia or insulin resistance to the pathogenesis of hypertension. Because impaired insulin-mediated NO production has been considered as an important factor for the pathogenesis of hypertension and type 2 diabetes, 20 the aim of the present study was to use somatostatin and euglycemic and insulin clamp techniques to quantify the contribution of acute hyperinsulinemia to blood pressure (BP) regulation and NO production in normal and fructose-induced insulin-resistant rats.
Methods

Animals and Surgical Procedures
Male Sprague-Dawley rats (5 to 6 weeks old) were purchased from the National Laboratory Animal Breeding and Research Center (Taipei, Taiwan). The rats were housed in regular cages in an animal room with a constant temperature of 22 Ϯ 1°C and a fixed 12-h light-dark cycle. All animals were handled and housed according to the guidelines of the Committee of the Care of Laboratory Animals of National Defense University-National Defense Medical Center.
The rats were randomly assigned to four groups: rats in groups C I and C NI (n ϭ 8/group) were fed regular chow diets. Rats in groups F I and F NI (n ϭ 8/group) were fed a 60% fructose-enriched diet (TD89247; Teklad Primer Labs, Madison, WI). After 8 weeks on their respective diets, rats were catheterized with microrenathane implantation tubing (0.04-in outer diameter by 0.25-in inner diameter and 0.33-in outer diameter by 0.14-in inner diameter) in the left femoral artery for BP measurement and blood sampling and in the femoral vein for solution infusion, and the proximal ends of the tubes were placed in subcutaneous pockets in the scapular area under anesthesia. After recovery for 3 to 4 days, the rats were studied only if they had recovered to preoperative body weight and had normal stools and had consumed their entire daily food ration. On the morning of acute study, the proximal ends of the catheters were exteriorized, the catheters were cleared, and intravenous and intra-arterial accesses were established.
Experimental Designs
There was a 40-min basal period, followed by a 210-min experimental period. At time 0, constant infusions of the following solutions were begun, and these infusions were continued throughout experiment. Somatostatin (1.3 g/ kg/min; Bachem AG, Bubendorf, Switzerland) was infused to suppress endogenous insulin and glucagon secretion. Regular insulin (4 mU/kg/min, Actrapid; Novo Nordisk A/S, Denmark) was replaced in groups C I and F I to create a similar high insulin level (about threefold basal insulin levels of normal rats). The same infusion rate of vehicle instead of insulin was infused into groups C NI and F NI to create a similar low insulin level. In addition, a primed, continuous peripheral infusion of 50% dextrose was begun at time 0, so that the blood glucose level could be quickly clamped at the basal level. Blood samples of 0.05 mL were obtained from the femoral artery every 10 to 15 min for measurement of the whole blood glucose concentrations to allow maintenance of steady-state basal arterial glucose level. Large blood samples (0.4 mL) for data acquisition were obtained from the femoral artery at time 0, 60, 90, 120, 150, 180, and 210 min. The total blood loss over the whole experimental period was 7 mL/kg in each group. This was equal to the saline solution administered through the infusion lines. Thus, the total blood withdrawn was not more than the amount (7 mL/kg) shown previously to provoke stress and insulin resistance in glucose clamp studies in anesthetized rats.
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BP Measurements
Direct BP measurements were performed in the experimental rats in the conscious state by connecting the femoral artery catheter to a polygraph (Gould RS3400 4-ch recorder; Gould Inc., Valley View, OH) through a pressure transducer for arterial pressure and heart rate monitoring.
Chemical Analysis
Whole blood glucose levels were assayed by the glucose oxidase method with a YSI glucose analyzer (YSI 2300 Plus; Yellow Springs Instruments, Yellow Springs, OH). Plasma triglyceride levels were determined by using appropriate enzymatic colorimetric methods (Roche Mira plus; Roche Diagnostic System, Inc., Basel, Switzerland). Plasma insulin levels were measured by the solid phase two-site enzyme immunoassay techniques using a commercially available kit provided by ALPCO (rat insulin ELISA kit; Mercodia AB, Uppsala, Sweden). Determination of NOx (the sum of nitrate and nitrite) required that NO 3 Ϫ first be reduced to NO 2 Ϫ by Aspergillus nitrate reductase and then NO 2 Ϫ was determined by the Griess reaction as described elsewhere. 22 The index of insulin sensitivity (M) was determined by the mean of the glucose infusion rates in the last 60-min period of the 210-min experimental period. 23 
Statistical Analysis
Statistical analysis was performed according to the repeated measurements of one-way analysis of variance (ANOVA) followed by Bonferroni's test. A probability of P Ͻ .05 was taken to indicate a significant difference between means. Values are expressed as means Ϯ SEM.
Results
Plasma Insulin, Triglycerides, Glucose Concentrations, and M Value
All groups of rats have similar glucose levels in the basal and euglycemic clamp periods (Table 1 ). In the basal period, plasma insulin concentrations were about twofold higher in fructose-fed groups than in control groups. During the experimental period, somatostatin infusion suppressed endogenous insulin secretion, so the rats without insulin infusion (groups C NI and F NI ) have significantly lowered insulin levels compared with the basal period. In control and fructose-fed groups with insulin infusion (C I and F I ), insulin (4 mU/kg/min) was co-infused with somatostatin to create a similar hyperinsulinemic state (threefold basal insulin level). In the basal period, plasma triglyceride concentrations were about fivefold higher in the fructose-fed groups than in the control groups. The plasma triglyceride levels were the same throughout the experimental period in all groups of rats. Under euglycemic condition, the M value, an insulin sensitivity index, was significantly lower in fructose-fed rats than in control rats with insulin infusion (F I versus C I ) but was not different between fructose-fed and control rats without insulin infusion (F NI versus C NI ). Hemotocrit and body weight were not significantly different among groups.
Mean Arterial Pressure and Heart Rate
Rats on fructose feeding for 8 weeks exhibited significantly higher mean arterial pressure (MAP) than control rats in the basal period (Fig. 1) . In the experimental period, insulin infusion (4 mU/kg/min) for 90 min significantly increased MAP in control rats and MAP reached a plateau at 120 min after infusion. However, the same amount of insulin infusion only slightly increased the MAP in F I as compared to that at the corresponding time point in F NI . Furthermore, suppression of insulin secretion by somatostatin infusion did not alter MAP or heart rate in F NI and C NI . Heart rate was not significantly changed in all groups throughout the acute study.
Plasma NOx Concentration
In the basal period, there were no significant differences in the plasma NOx levels among the groups. However, insulin infusion gradually and significantly increased plasma NOx levels in control rats, but not in fructose-fed rats. No significant difference in the plasma NOx levels were observed between fructose-fed and control rats without insulin infusion (F NI versus C NI ) throughout the experimental period (Fig. 2) .
Discussion
The cardiovascular effect of insulin has been postulated to be involved in BP regulation. However, the contribution of hyperinsulinemia to hypertension remains undefined. In this study, we compared quantitatively the hyperinsulinemia-mediated pressor response and NO release in normal and fructose-induced, insulin-resistant rats. The results demonstrate that acute hyperinsulinemia significantly increased BP and NO release in normal rats. The plasma NO levels of fructose-fed, hyperinsulinemic rats was comparable to that of control rats during the basal period, suggesting a diminished insulin-stimulated NO release in fructose-treated rats. This suggestion is further supported by the observation that a lower plasma NO level in fructose-fed rats than in control rats was noted during the euglycemic, hyperinsulinemic clamp period, whereas the plasma insulin concentrations were similar in both groups. These observations suggest that the hyperinsulinemia-induced pressor effect and NO release are blunted in the fructose-induced insulin resistant state. The results are consistent with the previous study of Verma et al, 24 who demonstrated an impairment of endothelium-dependent relaxation response to acetylcholine in the superior mesenteric artery in fructose-treated rats.
Whether a defect in the endothelial NO-dependent relaxation contributes to the development of insulin-associated hypertension remains to be defined. 25 Some studies showed that inhibition of NO synthesis by N -nitro-Larginine methyl ester (L-NAME; a nonselective NO synthase inhibitor) enhanced insulin-induced BP elevation in rats with chronic administration of exogenous hyperinsulinemia. 26, 27 In contrast, Navarro-Cid et al 28 reported in an in vitro study that the mesenteric vascular responses to acetylcholine and L-NAME were not different between control and fructose-induced hypertensive rats. Our study's results have shown that the diminished insulinstimulated NO release was not accompanied by an enhancement of a pressor effect in fructose-treated rats. In addition, we also found that acute infusion of somatostatin infusion significantly ameliorated fructose-induced hyperinsulinemia but failed to alter the elevated BP level in fructose-fed rats. Whether these controversial observations on the contribution of NO to the pathogenesis of insulinassociated hypertension is due to differences between in vivo and in vitro studies or due to different insulin-associated hypertensive models remains to be determined. Nevertheless, the potential role of decreased insulin-mediated NO production in the pathologic process of fructose-induced hypertension could not be ignored.
The sustained increase in plasma insulin level raises the BP in rats but not in normotensive humans or dogs. 29 The reason for the diverse arterial pressure responses to hyperinsulinemia in different species are not definitely known but may be due to species difference in the pressor and depressor actions of insulin. Consistent with previous studies, 7, 8, 10, 26, 30 insulin infusion significantly elevated BP in normal rats. Moreover, hyperinsulinemia-induced hypertension was accompanied with increases of NO release. However, acute insulin-induced pressor and NO effects were attenuated in rats fed a fructose diet. Theoretically, the cardiovascular effect of increased NO is expected to play a counterbalance role in the increase in BP. In contrast, a decrease in NO production is expected to increase BP. If the insulin-induced attenuation of NO production had existed during fructose feeding, the decreased NO release should substantially contribute to the pathogenesis of high BP in this hypertensive model.
In addition to the potential role of NO in the development of hyperinsulinemia-induced hypertension, previous studies have shown that insulin can also promote renal sodium retention 8 -10 and stimulate the sympathetic nerve system, [5] [6] [7] which can lead to an increase in BP. A rightshifted renal arterial pressure-natriuretic response has been demonstrated in rats with chronic hyperinsulinemia, suggesting an altered renal function in this hypertensive rat model. 8, 10, 26 On the other hand, ganglion blockade and sympathectomy can attenuate the insulin-stimulated pres- sor response, suggesting an inducing role of sympathetic neural mechanism in insulin-associated hypertension in rats. 6, 29, 31 Furthermore, sustained hyperinsulinemia has been documented to cause vascular medial hyperplasia, arterial stiffness, and luminal narrowing, and hence lead to increases in the peripheral vascular resistance and BP. 32, 33 Also, vascular insulin resistance has been demonstrated in fructose hypertensive rats. 34 Thus, it is likely that the structural alterations in the cardiovascular system and the vascular insulin resistance under chronic hyperinsulinemia could also be the factors for the different pressor responses to insulin administration between control and fructosetreated rats.
In summary, we have demonstrated that hyperinsulinemia-induced elevations of BP and NO release were attenuated under a state of fructose-induced insulin resistance in rats. The decrease in insulin-induced NO production contribute, at least partly, to the pathogenesis of fructoseassociated hypertension in rats.
